Blog

– enVVeno is developing the VenoValve as a potential treatment option for the approximately 2.5 million patients in the U.S. suffering from severe deep Chronic Venous Insufficiency

– FDA decision expected in 2H’2025

– Access the “What This Means” segment here

IRVINE, CA / ACCESS Newswire / August 4, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) (“enVVeno Medical” or the “Company”), a company setting new standards of care for the treatment of deep venous disease, today announced that it participated in a Virtual Investor “What This Means” segment entitled, “enVVeno Medical – Making Veins Work Again – How President Trump’s CVI Diagnosis is Raising Awareness.”

Rob Berman, CEO and Dr. Marc Glickman, CMO of enVVeno Medical discussed the progressive nature of chronic veinous insufficiency and whether President Trump may one day be a candidate for the VenoValve® following U.S. Food and Drug Administration (FDA) approval.

The Company estimates that there are approximately 2.5 million patients in the U.S. that could be candidates for the VenoValve. The Company has submitted a pre-market authorization (PMA) application for the VenoValve to the FDA, with a decision anticipated in the second half of 2025.

The “What This Means” segment can be accessed here.

About CVI

Severe deep venous CVI is a serious and debilitating disease that is most often caused by blood clots (deep vein thromboses or DVTs) in the deep veins of the leg. When valves inside of the veins of the leg fail, blood flows in the wrong direction and pools in the lower leg, causing pressure within the veins of the leg to increase (venous hypertension).

Symptoms of CVI include leg swelling, pain, edema, and in the most severe cases, recurrent open sores known as venous ulcers. The disease can severely impact everyday functions such as sleeping, bathing, dressing, and walking, and is known to result in high rates of depression and anxiety. There are currently no effective treatments that repair deep venous valve dysfunction, the #1 cause of severe CVI-a disease estimated to cost the U.S. healthcare system in excess of $26 billion each year.

About enVVeno Medical Corporation

enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company’s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the VenoValve U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe.

INVESTOR CONTACT:

Jenene Thomas, JTC Team, LLC
NVNO@jtcir.com
(908) 824-0775

MEDIA CONTACT:
Glenn Silver, FINN Partners
Glenn.Silver@finnpartners.com
(973) 818-8198

SOURCE: enVVeno Medical Corporation

View the original press release on ACCESS Newswire

MCLEAN, VA / ACCESS Newswire / August 4, 2025 / Gladstone Capital Corporation (Nasdaq:GLAD) (the “Company”) today announced earnings for its third quarter ended June 30, 2025. Please read the Company’s Quarterly Report on Form 10-Q filed today with the U.S. Securities and Exchange Commission (the “SEC”), which is available on the SEC’s website at www.sec.gov and the Investors section of the Company’s website at www.GladstoneCapital.com.

Summary Information (dollars in thousands, except per share data) (unaudited):

NM – not meaningful

Third Fiscal Quarter 2025 Highlights:

• Portfolio Activity: Invested $58.6 million in two new portfolio companies and $14.4 million in existing portfolio companies.

• Portfolio Mix: Secured first lien assets continue to be over 70% of our debt investments, at cost.

• Credit Facility: Increased the total commitment to $320.0 million and extended the revolving period end date to October 2027 and the final maturity to October 2029.

Third Fiscal Quarter 2025 Results:

Total investment income increased by $88 thousand, or 0.4%, for the quarter ended June 30, 2025, compared to the prior quarter ended March 31, 2025, driven primarily by a $0.6 million increase in other income, quarter over quarter, partially offset by a $0.5 million decrease in interest income. The increase in other income was driven by higher prepayment fees and dividend income compared to the prior quarter. Interest income decreased by $0.5 million, or 2.3%, quarter over quarter. The primary reason for the decrease was a decrease in the weighted average principal balance of our interest-bearing investment portfolio to $647.2 million during the quarter ended June 30, 2025 as compared to $682.6 million during the quarter ended March 31, 2025.

Total expenses were unchanged quarter over quarter. A decrease of $0.6 million in interest expense quarter over quarter was offset by a $0.5 million increase in the net base management and net incentive fees driven primarily by a reduction in the incentive fee credit quarter over quarter partially offset by higher investment banking fee credits to the base management fee from increased deal originations.

Net investment income for the quarter ended June 30, 2025 was $11.3 million, or $0.50 per share.

The net increase in net assets resulting from operations was $7.4 million, or $0.33 per share, for the quarter ended June 30, 2025, compared to $8.8 million, or $0.39 per share, for the quarter ended March 31, 2025. The current quarter increase in net assets resulting from operations was primarily driven by $11.3 million of net investment income, partially offset by $3.6 million of net realized loss recognized during the quarter.

Subsequent Events: Subsequent to June 30, 2025, the following significant events occurred:

• Portfolio Activity:

  • In July 2025, our $3.7 million debt investment in 8th Avenue Food and Provisions, Inc. paid off at par.

  • In July 2025, we invested $25.0 million in MASSiv Brands, LLC through secured first lien debt.

  • In July 2025, we invested $15.0 million in Alsay, Inc. through secured second lien debt and preferred equity.

  • In July 2025, we invested $23.7 million in Snif-Snax, LLC through secured first lien debt and preferred equity.

  • In July 2025, we invested $13.0 million in a precision manufacturing business through secured first lien debt and common equity. We also extended this business a $4.0 million secured first lien line of credit commitment, which was unfunded at close.

  • In August 2025, we invested an additional $16.6 million in OCI, LLC, an existing portfolio company, through secured first lien debt and common equity.

• Distributions and Dividends Declared:

  • In July 2025, our Board of Directors declared the following distributions to common and preferred stockholders:

• Comments from Gladstone Capital’s President, Bob Marcotte: “Over the past two quarters we have absorbed much of the anticipated surge in portfolio liquidity events and ended last quarter with a strong balance sheet and funding capacity. The underlying strength of our lower middle market deal focus was evident in the robust subsequent events fundings we reported and we are well on our way to growing the company’s investment portfolio to support shareholder distributions in the coming quarters.”

Conference Call for Stockholders: The Company will hold its earnings release conference call on Tuesday, August 5, 2025, at 8:30 a.m. Eastern Time. Please call (866) 424-3437 to enter the conference call. An operator will monitor the call and set a queue for any questions. A replay of the conference call will be available through August 12, 2025. To hear the replay, please dial (877) 660-6853 and use playback conference number 13754182. The replay of the conference call will be available beginning approximately one hour after the call concludes. The live audio broadcast of the Company’s quarterly conference call will also be available online at www.GladstoneCapital.com. The event will be archived and available for replay on the investors section of the Company’s website.

About Gladstone Capital Corporation: Gladstone Capital Corporation is a publicly-traded business development company that invests in debt and equity securities, consisting primarily of secured first and second lien term loans to lower middle market businesses in the United States. Information on the business activities of Gladstone Capital and the other publicly-traded Gladstone funds can be found at www.GladstoneCompanies.com.

To obtain a paper copy of the Company’s most recent Form 10-Q, please contact the Company at 1521 Westbranch Drive, Suite 100, McLean, VA 22102, ATTN: Investor Relations. The financial information above is not comprehensive and is without notes, so readers should obtain and carefully review the Company’s Form 10-Q for the quarter ended June 30, 2025, including the notes to the consolidated financial statements contained therein.

Investor Relations Inquiries: Please visit www.gladstonecompanies.com or (703) 287-5893.

Forward-looking Statements:

The statements in this press release about future growth and shareholder returns are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements inherently involve certain risks and uncertainties in predicting future results and conditions. Although these statements are based on our current plans that are believed to be reasonable as of the date of this press release, a number of factors could cause actual results and conditions to differ materially from these forward-looking statements, including those factors described from time to time in our filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect any future events or otherwise, except as required by law.

SOURCE: Gladstone Capital Corporation

View the original press release on ACCESS Newswire

ADELAIDE, AU / ACCESS Newswire / August 4, 2025 /

New assays up to 2,240 g/t Ag & 51.2 g/t Au in ‘Western Silver Zone’

HIGHLIGHTS

• March 2025 Tolmer discovery hole interval of 6m @ 4,747 g/t Ag from only 46m depth¹

• Re-assay of silver discovery hole also now confirms high-grade gold (4m @ 13.2g/t Au) from 48m, with silver up to 117 g/t Ag intersected within fresh rock zone for first time

• Key significant new assays:

  • extend shallow, broad ‘upper horizon’ of silver (~100 g/t Ag) in ‘oxide zone’;

  • extend ‘transitional / lower horizon’ of high-grade silver (~200 – 4,750 g/t Ag); and

  • add broad intervals of high-grade gold alongside silver in ‘lower horizon’, including:

Barton Gold Holdings Limited (ASX:BGD)(FRA:BGD3)(OTCQB:BGDFF) (Barton or Company) is pleased to report further assay results from its recent 2,882m reverse circulation (RC) drilling at its recent ‘Tolmer’ high grade silver discovery, located at the Company’s South Australian Tarcoola Gold Project (Tarcoola).²

Full details are contained in the complete announcement, which can be accessed on the ASX website, the investor section of Barton’s website, or directly by clicking here.

Commenting on the Tolmer drilling results, Barton Managing Director Alexander Scanlon said:

“The emergence of broad, high-grade gold alongside extensions of broad, high-grade silver is another exciting twist in the early days of the Tolmer story. This will be a very interesting feature to consider as we pursue a better understanding of our intriguing new discovery at the Tarcoola project. Diamond drilling will start next week.”

View the original press release on ACCESS Newswire

NEW YORK CITY, NEW YORK / ACCESS Newswire / August 4, 2025 / New to The Street, the 16-year media powerhouse known for national financial programming and multi-platform exposure, announces the official launch of a massive television commercial campaign for Synergy CHC Corp (NASDAQ:SNYR) – best known as the company behind Focus Factor®, the leading brain health supplement in the U.S.

This strategic media blitz will feature over 1,000 commercials across top national networks and local stations, bolstered by:

• NYC #1 Market Penetration via regional commercial placements and bus shelter ads

• NewsOut Video Press Release Coverage, including full production, distribution, and licensing

• Distribution across New to The Street’s YouTube channel with 3.2 million+ subscribers, one of the largest business media audiences globally

• TV rotation on FOX Business, Bloomberg Television, and national lifestyle networks

• Guaranteed earned media support through NewsOut’s press network and ABC/NBC/CBS affiliate access

• Outdoor visibility via Times Square billboards and Financial District placements (Accel Media)

“Synergy CHC and Focus Factor are household names with strong brand equity,” said New to The Street Founder Vince Caruso.

“This commercial campaign – backed by our unmatched reach on broadcast, digital, social, and outdoor – puts $SNYR in front of millions weekly. With NewsOut press releases complementing every push, this is one of the most complete visibility campaigns we’ve ever deployed.”

This marks a new chapter for Synergy CHC ($SNYR), combining decades of product recognition with cutting-edge media distribution that guarantees measurable, predictable exposure.

For media kits, bookings, or full broadcast schedules, contact:
Grace@NewToTheStreet.com
www.NewToTheStreet.com

About New to The Street

Since 2009, New to The Street has established itself as a leading media powerhouse, specializing in the production and broadcast of high-impact financial programming. With weekly sponsored broadcasts across prominent networks, including Bloomberg and FOX Business, we deliver unmatched exposure for our featured companies.

Beyond television, our extensive outdoor advertising footprint spans 17 iconic billboards strategically located throughout New York City, amplifying visibility in one of the world’s most dynamic markets. Additionally, New to The Street ranks among the top three largest buyers of TV commercial airtime across major networks such as FOX, CNBC, and Bloomberg, ensuring our clients achieve extensive reach and influence.

Our digital presence is equally commanding, boasting the largest social media platform in the industry with over 3.2 million dedicated subscribers. Through our integrated multimedia approach-combining national television, targeted outdoor advertising, strategic commercial placements, and a dominant online audience-New to The Street empowers brands with unparalleled media visibility and investor engagement.

Head Of Communications; Monica@NewtoTheStreet.com

SOURCE: New To The Street

View the original press release on ACCESS Newswire

TORONTO, ON / ACCESS Newswire / August 1, 2025 / Eskay Mining Corp. (“Eskay” or the “Company”) (TSXV:ESK)(OTC PINK:ESKYF)(Frankfurt:KN7)(WKN:A0YDPM) is pleased to announce the offering of a non-brokered private placement of up to $2 million of flow-through units (the “Offering“) to be sold to charitable purchasers (the “Charity FT Units“) at a price of C$0.56 per Charity FT Unit.

Each Charity FT Unit will consist of one common share of the Company (each, a “FT Share“) and one-half of a common share purchase warrant, each of which qualifies as a “flow-through share” within the meaning of the Income Tax Act (Canada) (the “Tax Act“). Each full warrant (a “Warrant“) shall entitle the holder to purchase one common share (a “Warrant Share“) at a price of C$0.65 at any time on or before that date which is 24 months after the Closing Date (as herein defined).

The gross proceeds from the sale of Charity FT Units will be used to incur “Canadian exploration expenses” as defined in subsection 66.1(6) of the Tax Act and “flow through mining expenditures” as defined in subsection 127(9) of the Tax Act, and for a subscriber who is a qualifying individual under the Income Tax Act (British Columbia) (the “BC Tax Act“), qualifies as a “BC flow-through mining expenditure” as defined in section 4.721(1) of the BC Tax Act (“Qualifying Expenditures“). The Qualifying Expenditures will be incurred on or before December 31, 2026, and renounced to the subscribers with an effective date not later than December 31, 2025, in the aggregate amount of not less than the total amount of gross proceeds raised from the issue of the Charity FT Units.

Proceeds from the Offering will be expended on the Company’s 100% controlled and consolidated Eskay Project in the heart of the Golden Triangle, British Columbia.

The Offering is scheduled to close on or around August 22, 2025 (the “Closing Date” or “Closing“) and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals including the approval of the TSX Venture Exchange. The securities issue will have a hold period of four months and one day from the closing of the Offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Charity FT Units, nor shall there be any sale of the Charity FT Units in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. The Charity FT Units being offered will not be, and have not been, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, a U.S. person.

About Eskay Mining Corp:

Eskay Mining Corp (TSX-V:ESK) is a TSX Venture Exchange listed company, headquartered in Toronto, Ontario. Eskay is an exploration company focused on the exploration and development of precious and base metals along the Eskay rift in a highly prolific region of northwest British Columbia known as the “Golden Triangle,” 70km northwest of Stewart, BC. The Company currently holds mineral tenures in this area comprised of 177 claims (52,600 hectares).

All material information on the Company may be found on its website at www.eskaymining.com and on SEDAR+ at www.sedarplus.com.

For further information, please contact:

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements: This Press Release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward-looking statements. Such statements reflect our current views with respect to future events and are subject to risks and uncertainties. Many factors could cause our actual results to differ materially from the statements made, including those factors discussed in filings made by us with the Canadian securities regulatory authorities. Should one or more of these risks and uncertainties, such as actual results of current exploration programs, the general risks associated with the mining industry, the price of gold and other metals, currency and interest rate fluctuations, increased competition and general economic and market factors, occur or should assumptions underlying the forward looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. Shareholders are cautioned not to put undue reliance on such forward-looking statements.

SOURCE: Eskay Mining Corp.

View the original press release on ACCESS Newswire

HUNTSVILLE, AL / ACCESS Newswire / August 4, 2025 / General Atomics Electromagnetic Systems (GA-EMS) returns to the Space and Missile Defense Symposium to highlight its missile defense solutions supporting Golden Dome, a layered missile defense architecture designed to protect the nation from a range of advanced missile threats including hypersonic, ballistic and cruise missiles, as well as other airborne threats.

GA-EMS will showcase the designs for their Bullseye™ missile and Long-Range Maneuvering Projectile (LRMP), with a 1:1 scale model and 1:2 scale model in their booth. The company has accelerated integration and testing of its missile defense technologies to demonstrate advanced capabilities and move rapidly toward field deployment.

“Our LRMP aligns with dynamic defense requirements for improved long-range precision strikes and minimizes operational uncertainty by integrating into existing artillery systems,” said Scott Forney, president of GA-EMS. “The next phase of full-system testing will validate the projectile’s performance across complex scenarios and ensure seamless integration with missile defense frameworks.”

Bullseye is a Technology Readiness Level (TRL) 8 missile system that shares 80% of its components with combat-proven TRL 9 missile systems, fully validated through successful real-world operations.

Attendees visiting Booth #531 will engage directly with GA-EMS experts to explore system designs and planned field-testing initiatives for both LRMP and Bullseye. GA-EMS will also feature its portfolio of laser weapon systems, hypersonics and sensor payloads for missile defense and tracking-offering greater flexibility and capability to support both offensive and defensive missions.

About General Atomics Electromagnetic Systems

General Atomics Electromagnetic Systems (GA-EMS) develops innovative technologies to create breakthrough solutions supporting operational environments from undersea to space. From electromagnetic, power generation and energy storage systems and space systems and satellites, to hypersonic, missile defense, and laser weapon systems, GA-EMS offers an expanding portfolio of capabilities for defense, government, and national security customers. GA-EMS also provides commercial products and services targeting hazardous waste remediation, oil and gas, and nuclear energy industries.

For further information, visit www.ga.com/ems

Contact Information

General Atomics Electromagnetic Systems Media Relations
Media Relations
ems-mediarelations@ga.com
858-253-3111

SOURCE: General Atomics Electromagnetic Systems

View the original press release on ACCESS Newswire

RICHARDSON, TX / ACCESS Newswire / August 4, 2025 / Optex Systems Holdings, Inc. (Nasdaq:OPXS), a leading manufacturer of precision optical sighting systems for domestic and worldwide military and commercial applications, announced today that it plans to report its financial performance for the third quarter of fiscal 2025 on Tuesday, August 12^th, 2025.

In addition, the Company announced that it will hold an investor conference call on August 12^th, 2025 at 5:00 pm ET. Investors interested in participating in the live call can dial (855) 459-0168 or (973) 413-6114 with the Conference Code 367887. Any financial information and required disclosure on non-GAAP financial measures discussed on the call will be included in the Company’s earnings release, which will be available at https://ir.stockpr.com/optexsys under “Latest Financial Results.”

ABOUT OPTEX SYSTEMS

Optex, which was founded in 1987, is a Richardson, Texas based ISO 9001:2015 certified concern, which manufactures optical sighting systems and assemblies, primarily for Department of Defense (DOD) applications. Its products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles, and have been selected for installation on the Stryker family of vehicles. Optex also manufactures and delivers numerous periscope configurations, rifle and surveillance sights, and night vision optical assemblies. Optex delivers its products both directly to the military services and to prime contractors. For additional information, please visit the Company’s website at www.optexsys.com.

Safe Harbor Statement

This press release contains, and the investor conference call will contain, certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to the products and services described herein. You can identify these statements by the use of the words “may,” “will,” “could,” “should,” “would,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” “likely,” “forecast,” “probable,” and similar expressions. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to, continued funding of defense programs and military spending, the timing of such funding, general economic and business conditions, including unforeseen weakness in the Company’s markets, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, changes in the U.S. Government’s interpretation of federal procurement rules and regulations, changes in spending due to policy changes in any new federal presidential administration, market acceptance of the Company’s products, shortages in components, production delays due to performance quality issues with outsourced components, inability to fully realize the expected benefits from acquisitions and restructurings or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, changes to export regulations, increases in tax rates, changes to generally accepted accounting principles, difficulties in retaining key employees and customers, unanticipated costs under fixed-price service and system integration engagements, changes in the market for microcap stocks regardless of growth and value and various other factors beyond our control.

You must carefully consider any such statement and should understand that many factors could cause actual results to differ from the Company’s forward-looking statements. These factors include inaccurate assumptions and a broad variety of other risks and uncertainties, including some that are known and some that are not. No forward-looking statement can be guaranteed and actual future results may vary materially. The Company does not assume the obligation to update any forward-looking statement. You should carefully evaluate such statements in light of factors described in the Company’s filings with the SEC, especially on Forms 10-K, 10-Q and 8-K. In various filings the Company has identified important factors that could cause actual results to differ from expected or historic results. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties.

Contact:

IR@optexsys.com
(972) 764-5718

SOURCE: Optex Systems Holdings, Inc.

View the original press release on ACCESS Newswire